The company has its headquarters in San Francisco and has more than 300 employees. Medivation got its first product approved in the year 2012.
Popular biotech products
XTANDI is the most popular biotech product of Medivation. This drug is indicated in patients with metastatic castration – resistant prostate cancer (mCRPC). Xtandi is solely meant for men and should in no way be used by women. Pregnant women and women of child – bearing age should also refrain from using this drug.
Though the use of this drug has proved to be effective for patients with prostate cancer, but this drug has also shown to have some side effects. These include back ache, fatigue, arthralgia, hot flush, edema, musculoskeletal pain, insomnia, dizziness, hematuria, anxiety, hypertension, lower respiratory tract infection, cauda equina syndrome and paresthesia.
Xtandi works by decreasing the tumor volume, induces death of the cancer cells and arrests as well as decreases cell growth. This drug in no way causes decrease in the levels of androgen, but works by inhibiting the binding of androgen to its receptors.
The scientists at Medivation are constantly striving to create new drugs for the treatment of diseases such as prostate cancer and breast cancer. The drug Xtandi has been developed for treatment of prostate cancer. The company in partnership with Astellas is in the process of developing enzalutamide for various stages of prostate and breast cancer.
Recent company takeovers
Medivation realizes the importance of partnerships and therefore enters into collaboration with various pharmaceutical firms for widening its area of research as well as developing several therapeutic products for treating life threatening diseases like cancer. In the year 2009, the firm joined hands with Astellas to develop and market enzalutamide. The collaboration was worth $110 million. Astellas would be responsible for developing the drug and marketing it and has also agreed to pay royalty to Medivation on the aggregate net sales of enzalutamide outside US.
Several efforts are also been made to test the efficacy of enzalutamide for the more advanced stages of prostate and breast cancer.
Recent corporate news
Medivation has been a member of the NASDAQ and is traded as MDVN. The last stock price was 56.53 on the 30th of August 2013.
Medivation considers its employees as its assets and the work environment in this firm is very fast paced and vibrant. The employees of this firm strive hard to conduct research and develop new and innovative therapies for treating deadly disease conditions. They are extremely confident and committed group of people who can take the company to new horizons. Employees at Medivation can go to any extent to serve the public at large by developing beneficial drug therapies.
The firm is always up for various interesting events and is an active participant in many conferences. The Morgan Stanley Global Health Conference is scheduled on the 10th of September, 2013.
Medivation has also taken part in two conferences in the month of August, 2013. These were Wedbush 2013 Life Sciences Management Access Conference and Medivation second quarter 2013 financial results conference call.
Recent job openings
Medivation is forever on the search of vibrant individuals with analytical minds who can deliver their best to the world and also are ready to undertake challenges. Interested individuals can drop in their resume and wait for the recruitment process. The following is the list of career opportunities with Medivation.
-Accounting, finance: There are several positions available in this field; such as director, tax, senior accountant, senior manager and senior financial analyst. For these positions, individuals need to have more than 10 years of experience in tax and relevant accounting. They should also have working knowledge on the several tax related subjects.
-Biometrics: The positions available are manager, clinical data manager, and senior statistical programmer. For these, the individuals need to have at least 7 – 10 years of experience in oncology studies and also have a basic knowledge of SAS.
-Clinical development: The positions in this field include clinical project manager, director of drug safety, manager of drug safety and clinical research associate. In order to apply for this position, the candidates need to undergo training in GCP and should have 2 years of experience in clinical research.
-Medical affairs: The available positions for this field include medical director and senior director of medical affairs. The individuals need to have at least 3 – 5 years of experience in pharmaceutical company and also have 2 years of experience in medical affairs. They also need to possess professional knowledge and skills in oncology.
-Medicinal chemistry: The available position for this field is associate director who are required to support the research work and the developmental activities and set goals for future work. The individuals need to have more than 6 years of experience in small molecule and drug discovery and its development.
-Pharmaceutical operations: Stability manager in pharmaceutical operations need to have at least 5 years of experience in GXP research laboratory. They also need to have experience in working with CMOs in a virtual environment.
-Pre clinical: The positions available in this field constitute of senior director, administrative assistant and associate director, and predictive diagnostics. For these positions, the individuals need to have experience that would suit each area of expertise. For applying for the post of administrative assistant, the individuals should have 5 – 7 years of experience as an administrative professional and should be an expert in operating Ms Office. For applying for the post of senior director, toxicology, the individuals should have 15 years of experience in a pharmaceutical industry and should have expertise in handling PhD level staff.